| 000 | 01387 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516211420.0 | ||
| 264 | 0 | _c20140701 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a0001-5385 | ||
| 024 | 7 |
_a10.1080/ac.69.2.3017291 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPuttevils, Daisy | |
| 245 | 0 | 0 |
_aIncreased cardiovascular risk in patients with rheumatoid arthritis: an overview. _h[electronic resource] |
| 260 |
_bActa cardiologica _cApr 2014 |
||
| 300 |
_a111-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 |
_aAtherosclerosis _xphysiopathology |
| 650 | 0 | 4 |
_aBelgium _xepidemiology |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xphysiopathology |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aDe Vusser, Philip | |
| 700 | 1 | _aGeusens, Piet | |
| 700 | 1 | _aDens, Jo | |
| 773 | 0 |
_tActa cardiologica _gvol. 69 _gno. 2 _gp. 111-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/ac.69.2.3017291 _zAvailable from publisher's website |
| 999 |
_c23783575 _d23783575 |
||